Advertisement

Peri-operative Care, ICU Care and Fluid Management

  • Rinaldo Bellomo
Chapter

Abstract

The peri-operative care of cardiac surgery patients is complex and dynamic. Hemodynamic management is of pivotal importance and, in many patients, requires invasive monitoring of filling pressures and cardiac output. In a significant proportion of patients hemodynamic support requires not only the administration of fluids but also the administration of vasopressor and inotropic drugs. Such therapy mandates continuous measurement of pressure and flow. In very unstable patients, mechanical intervention with intra-aortic balloon counterpulsation and extracorporeal membrane oxygenation may also become necessary. Management of bleeding can also become a problem and require aggressive administration of blood products or concentrated clotting factors. Adequate sedation, prevention of infection, treatment of acute renal failure, safe mechanical ventilation and treatment of metabolic and acid-base disorders are also frequent and important.

Keywords

Fluids Vasopresssors Inotropes Cardiac output Coagulation Infection 

References

  1. 1.
    Lalu MM, Pasini E, Schulze CJ, et al. Ischemia-reperfusion injury activates matrix metallopoteinases in the human heart. Eur Heart J. 2005;26:27–35.CrossRefPubMedGoogle Scholar
  2. 2.
    Scarabelli TM, Pasini E, Ferrari G, et al. Warm blood cardioplegic arrest induces mitochodrial-mediated cardiomyocyte apoptosis associated with increased urocortin expression in viable cells. J Thorac Cardiovasc Surg. 2004;128:364–71.CrossRefPubMedGoogle Scholar
  3. 3.
    Boldt J, Hammermann H, Hempelmann G. What is the place of the phosphodiesterase inhibitors? Eur J Anaesthesiol. 1993;8:33–7.Google Scholar
  4. 4.
    Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A, European Milrinone Multicenter Trial Group. Comparison of the haemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth. 2001;15:306–15.CrossRefPubMedGoogle Scholar
  5. 5.
    Polonen P, Ruokonen E, Hippelainen M, Poyhonen M, Takala J. A prospective, randomised study of goal-oriented haemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000;90:1052–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Lobato EB, Gravenstein N, Martin TD. Milrinone, not epinephrine, improves left venticular compliance after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2000;14:374–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Butterworth 4th JF, Prielipp RC, Royster RL, et al. Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardiothorac Vasc Anesth. 1992;6:535–41.CrossRefPubMedGoogle Scholar
  8. 8.
    Myles PS, Buckland MR, Schenk NJ, et al. Effect of “renal-dose” dopamine on renal function following cardiac surgery. Anaesth Intensive Care. 1993;21:56–61.PubMedGoogle Scholar
  9. 9.
    Romson JL, Leung JM, Bellows WH, et al. Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients. Anesthesiology. 1999;91:1318–28.CrossRefPubMedGoogle Scholar
  10. 10.
    Dupuis JY, Bondy R, Cattran C, Nathan HJ, Wynands JE. Amrinone and dobutamine as primary treatment of low cardiac output syndrome following coronary artery surgery: a comparison of their effects on hemodynamics and outcome. J Cardiothorac Vasc Anesth. 1992;6:542–53.CrossRefPubMedGoogle Scholar
  11. 11.
    Hurley J, McDonagh P, Cahill M, et al. The haemodynamic effect of prophylactic peri-operative dopexamine in coronary artery bypass patients. Eur Heart J. 1995;16:1705–9.PubMedGoogle Scholar
  12. 12.
    Doolan LA, Jones EF, Kalman J, Buxton BF, Tonkin AM. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1997;11:37–41.CrossRefPubMedGoogle Scholar
  13. 13.
    George M, Lehot JJ, Estanove S. Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: multicentre study. Eur J Anaesthesiol. 1992;5:31–4.Google Scholar
  14. 14.
    Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet. 2002;360(9328):196–202.CrossRefPubMedGoogle Scholar
  15. 15.
    Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery. Int J Clin Pharmacol Ther. 2004;42:204–11.CrossRefPubMedGoogle Scholar
  16. 16.
    Kerstein J, Soodan A, Qamar M, et al. Giving IV an doral amiodarone perioperatively for the prevention of post-operative atrial fibrillation in patients undergoing coronary artery bypass surgery. Chest. 2004;126:716–24.CrossRefPubMedGoogle Scholar
  17. 17.
    Bellomo R. Fluid resuscitation: colloids vs. crystalloids. Blood Purif. 2002;20:239–42.CrossRefPubMedGoogle Scholar
  18. 18.
    Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247–56.CrossRefPubMedGoogle Scholar
  19. 19.
    Van der Linden PJ, De Hert SG, Daper A, et al. 2.5% urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth. 2004;51:236–41.CrossRefPubMedGoogle Scholar
  20. 20.
    Bellomo R, Uchino S. Cardiovascular monitoring tools: use and misuse. Curr Opin Crit Care. 2003;9:225–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Reuter DA, Felbinger TW, Schmidt C, et al. Stroke volume variations for assessment of cardiac responsiveness to volume loading in mechanically ventilated patients after cardiac surgery. Intensive Care Med. 2002;28:392–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Bettex DA, Hinselmann V, Hellerman JP, et al. Transesophageal echocardiography is unreliable for cardiac output assessment after cardiac surgery compared with thermodilution. Anaesthesia. 2004;59:1184–92.CrossRefPubMedGoogle Scholar
  23. 23.
    Duncker DJ, Zhang J, Pavek TJ, et al. Effect of exercise on coronary pressure-flow relationship in hypertrophied left ventricle. Am J Physiol. 1995;269:H271–81.PubMedGoogle Scholar
  24. 24.
    Raman J, Kochi K, Morimatsu H, Buxton B, Bellomo R. Severe ischemic early liver injury after cardiac surgery. Ann Thorac Surg. 2002;74:1601–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Mekontso-Dessap A, Houel R, Soustelle C, et al. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg. 2001;71:1428–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Morimatsu M, Uchino S, Chung J, Bellomo R, Raman J, Buxton B. Norepinephrine for severe vasodilatation after cardiac surgery: impact on renal function. Intensive Care Med. 2003;29:1106–12.CrossRefPubMedGoogle Scholar
  27. 27.
    Lechner E, Dickerson HA, Fraser Jr CD, Chang AC. Vasodilatory shock after surgery for aortic valve endocarditis: use of low-dose vasopressin. Pediatr Cardiol. 2004;25:558–61.CrossRefPubMedGoogle Scholar
  28. 28.
    Davies A, Bellomo R, Raman JS, Gutteridge G, Buxton B. An elevated lactate is a useful predictor of mortality during intra-aortic balloon pumping in cardiac surgical patients. Ann Thorac Surg. 2000;71:1415–20.CrossRefGoogle Scholar
  29. 29.
    Smith C, Bellomo R, Raman J, et al. The outcome of an integrated ECMO-based approach to post-cardiotomy cardiogenic shock in an older population. Ann Thorac Surg. 2000;71:1421–7.CrossRefGoogle Scholar
  30. 30.
    Raman J, Hata M, Bellomo R, Kochi K, Cheung H, Buxton B. Hemofiltration during prolonged cardiopulmonary bypass. Int J Artif Organs. 2003;26:753–7.PubMedGoogle Scholar
  31. 31.
    Bent P, Tan HK, Bellomo R, et al. Early and intensive continuous veno-venous hemofiltration for severe acute renal failure after cardiac surgery. Ann Thorac Surg. 2001;71:832–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Liu G, McNicol L, McCall P, Bellomo R, et al. Prediction of the mediastinal drainage after coronary artery bypass surgery. Anaesth Intensive Care. 2000;28:420–6.PubMedGoogle Scholar
  33. 33.
    Kowey PR, Taylor JE, Rials SJ, et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary bypass surgery. Am J Cardiol. 1992;69:963–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Shiga T, Wajima Z, Inoue T, Oagawa R. Magnesium prophylaxix for arrhytmias after cardiac surgery: a meta-analysis of randomized controlled trials. Am J Med. 2004;117:325–33.CrossRefPubMedGoogle Scholar
  35. 35.
    Camm JA, Capucci A, Hohnloser SH, et al. A randomised active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. J Am Coll Cardiol. 2011;57:313–21.CrossRefPubMedGoogle Scholar
  36. 36.
    Pratt CM, Roy D, Torp-Pedersen C, et al. Usefulness of vernakalant hydrochloride injection for rapid conversion of atrial fibrillation. Am J Cardiol. 2010;106:1277–83.CrossRefPubMedGoogle Scholar
  37. 37.
    Opdam H, Bellomo R. Oxygen consumption and lactate release by the lung after cardiopulmonary bypass and during septic shock. Crit Care Resusc. 2000;2:181–7.PubMedGoogle Scholar
  38. 38.
    Hayhoe M, Bellomo R. The pathogenesis of acid-base changes during cardiopulmonary bypass. Curr Opin Crit Care. 1999;5:464–7.CrossRefGoogle Scholar
  39. 39.
    Hayhoe M, Bellomo R, Liu G, Kellum JA, McNicol L, Buxton B. The role of the splanchnic circulation in acid-base balance during cardiopulmonary bypass. Crit Care Med. 1999;27:2671–7.CrossRefPubMedGoogle Scholar
  40. 40.
    Liskaser F, Bellomo R, Hayhoe M, et al. Role of pump prime in the etiology and pathogenesis of cardiopulmonary bypass-associated acidosis. Anesthesiology. 2000;93:1170–3.CrossRefPubMedGoogle Scholar
  41. 41.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359–67.CrossRefPubMedGoogle Scholar
  42. 42.
    Brasher PA, McClelland KH, Denehy L, Story I. Does removal of deep breathing exercises from a physiotherapy program including pre-operative education and early mobilization after cardiac surgery alter patient outcomes? Aust J Physiother. 2003;49:165–73.CrossRefPubMedGoogle Scholar
  43. 43.
    Davies A, Froomes P, French C, Bellomo R, et al. Randomized comparison of nasojejunal and nasogastric feeding in critically ill patient. Crit Care Med. 2002;30:586–90.CrossRefPubMedGoogle Scholar
  44. 44.
    Bersten AD, Edibam C, Hunt T, et al. Incidence and mortality of acute lung injury and the acute respiratory distress syndrome in three Australian states. Am J Respir Crit Care Med. 2002;165:443–8.CrossRefPubMedGoogle Scholar
  45. 45.
    Hebert PC, Wells G, Blajchman MA, et al. A multicentre, randomized controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340:409–17.CrossRefPubMedGoogle Scholar
  46. 46.
    Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;358:1229–39.CrossRefPubMedGoogle Scholar
  47. 47.
    Vanderheyden BA, Reynolds HN, Gerold KB, et al. Prolonged paralysis after long-term vecuronium infusion. Crit Care Med. 1992;20:304–7.CrossRefPubMedGoogle Scholar
  48. 48.
    Koleff MH, Levy NT, Ahrens TS, et al. The use of continuous IV sedation is associated with prolonged mechanical ventilation. Chest. 1998;114:541–8.CrossRefGoogle Scholar
  49. 49.
    Reade MC, O’Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R. Dexmedetomidine vs. haloperidol in delirious agitated, intubated patients: a randomized open-label trial. Crit Care. 2009;13:R75.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag London Ltd. 2016

Authors and Affiliations

  1. 1.Department of Intensive Care and Department of MedicineAustin Hospital and University of MelbourneHeidelbergAustralia

Personalised recommendations